Orforglipron side effects Common orforglipron side effects reported in trials are similar to other GLP-1 drugs and mainly affect the digestive system
DPP-4 inhibitors in the management of type 2 diabetes: A critical review of head-to-head trials
How Retatrutide Differs From Other Weight-Loss Compounds Retatrutide vs GLP-1-Only Compounds GLP-1-only compounds focus mainly on appetite reduction
Join over 50,000 patients who trust Hi-Doctor, reflected in our 4.8 Trustpilot rating
Discussion In this model-based analysis of phase III randomized trials in individuals with T2DM, we observed that semaglutide and tirzepatide exhibit broadly comparable pharmacodynamic profiles for weight reduction when evaluated across clinically relevant dose ranges
Band intensities were quantified using ImageJ software (National Institutes of Health [NIH], Bethesda, MD, USA